The MFDS monitors drug safety post-approval through pharmacovigilance programs, adverse event reporting, and periodic safety updates from manufacturers. It conducts inspections, risk assessments, and may request additional studies if necessary. The MFDS can issue warnings, modify drug labeling, or withdraw approvals to ensure ongoing public safety.